Delivery Order SPE2DB20D3101-SPE2DB25FRSF9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,129.70 to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply fulfillment under AmerisourceBergen's broader relationship with the federal government. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of the...
- The Defense Logistics Agency awarded a delivery order valued at $20,061.21 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 mL vials on July 23, 2025, with completion scheduled for July 24, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its corporate office location. This...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Bridion 200 mg/2 mL vials. This firm fixed-price delivery order, valued at $1,577.68, represents a competitively awarded contract with an ultimate completion date of July 22, 2025. The award was issued without a set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete for federal medical procurement requirements....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on July 29, 2025, for Bridion 500 mg/5 mL vials, with a ceiling value of $35,252.62 under firm fixed-price terms. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This competitively awarded, non-set-aside delivery order is...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $131,234.68 on July 29, 2025, for the supply of Bridion 200mg/2mL (10 units). This competitively awarded, firm fixed price contract is not set-aside and will be completed by August 25, 2025. The award is funded by the Defense Logistics Agency's Medical Supply Chain division and represents a child delivery order under AmerisourceBergen's larger prime Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a $30,552.77 delivery order to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 mL vials on July 29, 2025, with a completion date of July 30, 2025. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to the company's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 21, 2025, for the supply of Bridion 200mg/2ml (10 units) with a ceiling value of $24,536.83. This firm fixed-price, competitively awarded delivery order is funded by the Defense Logistics Agency's Medical Supply Chain division and is scheduled for completion by August 15, 2025. The contract represents a child order under AmerisourceBergen's larger...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $2,673.61 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Bridion 200 mg/2 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. The award represents a continuation of...
- AmerisourceBergen Drug Corp received a $4,798.93 firm fixed price delivery order from the Defense Logistics Agency (DLA) on July 21, 2025, for Bridion 200 mg/2 ml vials. The contract is non-set-aside and competitively awarded, with an ultimate completion date of July 22, 2025. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $49,070.00 on August 5, 2025, for the supply of Bridion 200 mg/2 mL vials. This firm fixed-price, non-set-aside contract is being funded by the Defense Logistics Agency's Medical Supply Chain and will be completed by August 6, 2025. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRSF9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $27,945.02 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 ml vials on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare supplier, fulfills this order under its existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. This delivery order exemplifies AmerisourceBergen's role as a prime vendor supporting military and federal healthcare systems through the DLA's Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to deliver a wide spectrum of pharmaceutical products, including specialty medications and branded drugs, to support Defense Health Agency, U.S. Coast Guard, and other government healthcare operations worldwide. The Bridion supply fulfills critical medical needs within the company's established IDC framework, which enables flexible procurement of pharmaceutical commodities across multiple therapeutic domains to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.9k | 8/11/25 |